Mefloquine + azithromycin + / - tocilizumab for respiratory insufficiency

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Apr 2020: Trial started, NCT04347031
  2. 15 Apr 2020: Trial registered, NCT04347031

The trials

NCT04347031: A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19

State
Completed
Phase
Phase 2 and Phase 3
People
320 taking part
Started
8 Apr 2020
Primary completion
1 Nov 2020
Arms
group 2 cohort 1
Results
None posted
  1. 8 Apr 2020: Trial started
  2. 15 Apr 2020: Trial registered
  3. 20 Nov 2020: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.